Professor Keyoumars Ashkan
Professor of Neurosurgery
- Lead Clinician for Neuro-Oncology
- Chair of King’s Neurosciences Clinical Trial Unit
Research interests
- Neuroscience
Contact details
Biography
I have a specialist interest in functional neurosurgery, image guided surgery and surgery for brain and spinal tumours. In addition to my clinical work, I am actively involved in research, especially in developing novel treatments for brain tumours and for Parkinson's disease. I am the deputy lead for neurosciences Research Advisory Group at King's College Hospital, the President of the British Society for Stereotactic and Functional Neurosurgery, Chairman of the Surgical Group of the International Parkinson and Movement Disorder Society, and Lead for the Genomics England programme for brain tumours. I have published over 400 peer review papers, abstracts and book chapters and I was voted 'Clinician of The Year' by the Brain Tumour Charity in 2018.
Please see my Research Staff Profile for more detail.
Key publications:
- Eitan et al., 2018. One year double blind study of high vs low frequency subcallosal cingulate stimulation for depression. Journal of Psychiatric Research.
- Liau et al., 2018. First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma. Journal of Translational Medicine.
- Ashkan et al., 2017. Insights into the mechanisms of deep brain stimulation. Nature Reviews Neurology.
- deSouza et al., 2016. Has the survival of patients with glioblastoma changed over the years? British Journal of Cancer.
- Lumsden et al., 2015. Observation and modeling of deep brain stimulation electrode depth in the pallidal target of the developing brain. World Neurosurgery.
Research
Maudsley Neurotechnology (MNT)
Maudsley Neurotechnology is a clinical and academic centre for evaluating and delivering evidence-based neurotechnology treatments for mental health disorders
News
NIHR i4i product development award received for novel imaging system
The system will make brain tumour removal surgery safer and more complete
Researchers win grant allowing cross-school collaboration to examine if immunogenic cell death can be exploited in brain cancer
New project aims to develop a new treatment option for brain cancer.
Research
Maudsley Neurotechnology (MNT)
Maudsley Neurotechnology is a clinical and academic centre for evaluating and delivering evidence-based neurotechnology treatments for mental health disorders
News
NIHR i4i product development award received for novel imaging system
The system will make brain tumour removal surgery safer and more complete
Researchers win grant allowing cross-school collaboration to examine if immunogenic cell death can be exploited in brain cancer
New project aims to develop a new treatment option for brain cancer.